Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
D6355-07 – Standard Test Method Technical Guide
🧪 Scope and Foundational Principles of Human RIPT
ASTM Standard D6355-07 (Reapproved 2022) provides a standardized test method for evaluating the potential of medical glove materials to induce and elicit Type IV skin sensitization (allergic contact dermatitis, or ACD) in human subjects. This protocol is specifically designed for use by professionals experienced in clinical trial procedures and good clinical practice.
Originally validated by Draize in 1944, the core structure of the Human Repeat Insult Patch Test (RIPT) relies on a specific multi-phase approach to detect delayed hypersensitivity reactions to chemical allergens used in glove manufacturing.
| 📐 Test Phase | ⚡ Key Requirement |
|---|---|
| Induction | Multiple patch applications at relatively non-irritating or low irritancy levels |
| Rest Period | Approximately two weeks |
| Challenge | Standard 48-hour diagnostic patch |
| Delayed Reading | Approximately 96 hours after patch application |
⚠️ Key Consideration: Subsequent research has highlighted the enhanced sensitivity achieved through increased study material concentration, the use of occlusion where it would not ordinarily be present, and careful definition of a no-effect level for individual ingredients.
📋 Clinical Procedure, Scoring, and Interpretation
A critical responsibility of the investigator is differentiating between an irritant (non-immunologic) response and true allergic contact dermatitis. The numerical scoring systems for both are similar, making clinical judgment paramount. Hallmarks of a mild ACD reaction include a sustained palpable erythematous reaction that favors higher scores over longer durations. In contrast, irritant reactions typically produce minimal scores for short periods.
| 🟦 Response Feature | 🟨 Irritant Reaction | 🟩 Allergic Contact Dermatitis (ACD) |
|---|---|---|
| Duration | Short (less than 48 hours) | Sustained (longer than 48 hours) |
| Typical Score | Minimal (e.g., Score 1: just-perceptible erythema) | Higher values, sustained intensity |
| Palpable Erythema | Less common | Sustained presence (Hallmark of a mild reaction) |
| Immunologic Basis | Non-immunologic | Type IV Delayed Hypersensitivity |
💡 Expert Tip: The investigator must denote a final score as either due to contact allergy or irritation, guided by the detailed criteria in Paragraphs 9.5–9.5.5 of the standard.
📊 Statistical Significance and Panel Size Limitations
A foundational challenge in RIPT testing is the statistical power of small sample sizes. The standard references the work of Henderson and Riley (1945), which established that a test panel of 30,000 subjects would be required to ensure a sensitization rate of no more than 0.1%.
All medical devices must be safe and effective for their intended use. Since devices such as gloves come in contact with human tissue, biocompatibility testing in animals is recommended prior to human testing. The RIPT is one tool for assessing skin sensitization to chemicals used in glove manufacturing, but its limitations must be understood.
⚠️ Important Statistical Note: According to the standard, if no allergic responses are observed in a test panel of 200 subjects, the statistical data allows for the possibility of up to 1.5 allergic reactions per 100 users in the general population. This underscores the importance of robust statistical power and supplementary biocompatibility testing.
❓ Frequently Asked Questions
🔍 What specific allergic reaction does ASTM D6355 evaluate?
The standard evaluates the potential of medical glove materials to induce and elicit Type IV skin sensitization, also known as allergic contact dermatitis (ACD), a delayed hypersensitivity immune response.
💡 How does the RIPT distinguish between an allergic reaction and simple irritation?
Investigators evaluate the duration and intensity of skin responses. Allergic contact dermatitis characteristically presents as a sustained palpable erythematous reaction with higher intensity scores lasting over 48 hours. Irritant reactions are typically transient and produce minimal scores (e.g., score of 1, a just-perceptible erythema) for less than 48 hours.
⚡ What is the main statistical limitation cited in the standard?
The standard highlights that a panel of 200 subjects showing no allergic responses does not guarantee absolute safety. Statistically, up to 1.5 allergic reactions per 100 users could still occur in the general population, demonstrating the need for large sample sizes or supplementary testing for a comprehensive safety profile.
📌 What are the three key phases of the Draize RIPT?
1) Multiple induction patches of the study material at non-irritating or low irritancy levels. 2) An approximate two-week rest period. 3) A standard 48-hour diagnostic challenge patch with a delayed reading at approximately 96 hours after application.